Finance

Senarai
002773:SHE
Chengdu Kanghong Pharma Grp Co Ltd
CN¥20.25
-1.98%
(-0.41) 1H
12 Okt, 10:26:42 PG GMT+8  ·   CNY
Semua simbol
SimbolHargaPerubahan% Perubahan
Menjana cerapan popular untuk 002773...
Buka
CN¥20.82
Tinggi
CN¥20.88
Rendah
CN¥20.11
Permodalan Pasaran
19.03B
Purata volum
7.67J
Volum
4.09J
Dividen
3.46%
Dividen suku tahunan
CN¥0.17
Tarikh tanpa dividen
9 Jun 2026
Nisbah H/P
18.75
tgi 52 mgu
CN¥36.10
rdh 52 mgu
CN¥18.62
EPS
CN¥1.08
Syer tertunggak
921.33J
Bilangan pekerja
4K
Buka
CN¥20.82
Tinggi
CN¥20.88
Rendah
CN¥20.11
Permodalan Pasaran
19.03B
Purata volum
7.67J
Volum
4.09J
Dividen
3.46%
Dividen suku tahunan
CN¥0.17
Tarikh tanpa dividen
9 Jun 2026
Nisbah H/P
18.75
tgi 52 mgu
CN¥36.10
rdh 52 mgu
CN¥18.62
EPS
CN¥1.08
Syer tertunggak
921.33J
Bilangan pekerja
4K
Cerita berita
Daripada sumber web dan rakan kongsi berita
Profil
Chengdu Kanghong Pharmaceutical Group Co., Ltd. is a publicly traded pharmaceutical company based in the province of Sichuan, China. It was founded in 1996 and researches, develops, manufactures, and distributes medicines for ophthalmic, central nervous, digestive and endocrine systems. The company is listed on the Shenzhen stock exchange with a market capitalization at around $6 billion. As of May 2021, the company had 18 drugs on the market including Lumitin. Additional products include Songling xuemaikang capsules, Keluoxin capsules, Xinluona, Bolexin and Bosiqing, Yitaning, Shugan Jieyu, Danshu, and Yiqing. Kanghong also currently has 13 subsidiaries in China, Israel, and the United States. Wikipedia
Perihal Chengdu Kanghong Pharma Grp Co Ltd
CEO-
Pekerja4.47K
Diasaskan3 Okt 1996
Ibu pejabat-
Sektor-
Laman webcnkh.com
Laporan sebelumnyaSemua nilai dalam CNY
Loading Previous Earnings...
Hasil
Pendapatan bersih
Semua nilai dalam CNY
Sep 2025
Dis 2025
Mac 2026
Jun 2026
Hasil
1.17B
961.27J
1.05B
1.13B
Kos barangan yang dijual
103.16J
116.91J
118.65J
132.03J
Kos hasil
103.16J
116.91J
118.65J
132.03J
Perbelanjaan penyelidikan dan pembangunan
119.54J
198.94J
86.77J
138.57J
Jumlah perbelanjaan penyelidikan dan pembangunan
-
-
-
-
Perbelanjaan jualan, am dan pentadbiran
595.28J
521.75J
478.88J
554.55J
Belanja kendalian
697.02J
764.40J
582.81J
717.78J
Jumlah belanja kendalian
800.18J
881.31J
701.46J
849.80J
Pendapatan kendalian
370.02J
79.96J
345.02J
282.88J
Pendapatan bukan kendalian lain
-19.53J
19.27J
-1.04J
-1.54J
EBT termasuk item luar biasa
355.99J
147.66J
358.51J
301.88J
EBT tidak termasuk item luar biasa
364.66J
135.96J
356.39J
306.28J
Belanja cukai pendapatan
56.73J
23.28J
55.31J
50.13J
Kadar cukai berkesan
15.94%
15.77%
15.43%
16.61%
Belanja kendalian lain
-17.83J
43.89J
16.62J
23.18J
Pendapatan bersih
303.21J
130.06J
307.48J
257.26J
Margin untung bersih
25.91%
13.53%
29.38%
22.71%
Perolehan bagi setiap syer
-
-
-
-
Pendapatan faedah dan pelaburan
14.20J
36.91J
12.63J
24.92J
Belanja faedah
-
-
-
-
Belanja faedah bersih
14.20J
36.91J
12.63J
24.92J
Caj susut nilai dan pelunasan
-
-
-
-
EBITDA
427.31J
139.05J
404.11J
345.15J
Keuntungan atau kerugian daripada jualan aset
3.47K
-9.78K
-
61.06K
Kandungan AI boleh mengandungi kesilapan. Ketahui lebih lanjut
BantuanHantar maklum balasPrivasiSyaratPenafian
Apl Google